PureTech’s PRTC reports positive Phase 1 GlyphAllo topline results
PureTech Health plc says Seaport Therapeutics has reported positive topline Phase 1 results from a GlyphAllo simulation trial in healthy volunteers.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.